Reviews in Cardiovascular Medicine

Editorial Board

MEDICAL EDITOR

photo

Norman E. Lepor MD, FACC, FAHA, FSCAI

Cedars-Sinai Medical Center

Known for his interest in graduate medical education and investigations in the field of interventional cardiology, Dr. Lepor is cofounder of Reviews in Cardiovascular Medicine. He is Clinical Professor of Medicine at The David Geffen School of Medicine at UCLA and an attending cardiologist at Cedars-Sinai Medical Center. He has directed investigations into the study of interventions in acute myocardial infarction, coronary artery brachytherapy, prevention of contrast nephropathy, percutaneous transmyocardial revascularization and oral antiplatelet, and anticoagulant drugs. Dr. Lepor has lectured widely on topics including the use of glycoprotein IIb/IIIa platelet receptors, contrast nephropathy, and prevention of coronary artery disease.


Peter A. McCullough MD MPH FACC FACP FCCP FAHA FNKF

Baylor University Medical Center

Expertise: Cardiorenal Syndromes

 

After receiving a bachelor’s degree from Baylor University, Dr. McCullough completed his medical degree as an Alpha Omega Alpha graduate from the University of Texas Southwestern Medical School in Dallas.  He went on to complete his internal medicine residency at the University of Washington in Seattle, cardiology fellowship including service as Chief Fellow at William Beaumont Hospital, and master’s degree in public health at the University of Michigan.  Dr. McCullough directs cardiovascular education and research for the Baylor Health Care System and is a Vice Chief of Medicine at Baylor University Medical Center in Dallas, TX.  He is an internationally recognized authority on the role of chronic kidney disease as a cardiovascular risk state with over 1000 publications.  Dr. McCullough has won numerous awards including in the Simon Dack Award from the American College of Cardiology for outstanding scholarship and the International Vicenza Award for Critical Care Nephrology for his contributions and dedication to the emerging problem of cardiorenal syndromes. 




ASSOCIATE EDITOR

Gregg C. Fonarow MD, FACC

The David Geffen School of Medicine at UCLA

Expertise: Congestive Heart Failure

An eminent specialist in heart failure management and preventative cardiology, Dr. Fonarow holds the Eliot Corday Chair in Cardiovascular Medicine and is Science Professor of Medicine, Division of Cardiology, The David Geffen School of Medicine at UCLA, Director of the Ahmanson-UCLA Cardiomyopathy Center, and Director of the UCLA Cardiology Fellowship Training Program.


Gregg W. Stone MD, FACC, FSCAI

Columbia University Medical Center

Expertise: Interventional Cardiology

Dr. Stone is Professor of Medicine at Columbia University, Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapies at Columbia University Medical Center, and Chairman of the Cardiovascular Research Foundation in New York, NY. Dr. Stone has served as the lead principal investigator for more than 25 national and international multicenter randomized trials, and is the co-director of Transcatheter Cardiovascular Therapeutics, the world’s largest symposium devoted to interventional cardiology and vascular medicine. He directs the annual National Interventional Cardiology Fellow’s Course and numerous other annual courses. Dr. Stone’s medical practice is devoted to interventional cardiology at Columbia University Medical Center. Dr. Stone has served as has authored more than 600 book chapters, manuscripts and abstracts published in the peer-reviewed literature, and has delivered more than 1000 invited lectures around the world. Dr. Stone’s areas of expertise include interventional therapies of acute coronary syndromes and myocardial infarction; drug eluting stents; adjunct pharmacology; new device angioplasty including distal embolic protection, thrombectomy, vascular brachytherapy and stent grafts; intravascular ultrasound imaging; saphenous vein graft therapies; chronic total occlusions; vulnerable plaque; contrast nephropathy; clinical trial design; and regulatory issues. 




EDITORIAL BOARD MEMBER

William T. Abraham MD

The Ohio State University College of Medicine

Expertise: Heart Failure

William T. Abraham, M.D., F.A.C.P., F.A.C.C. is Professor of Internal Medicine and Chief of the Division of Cardiovascular Medicine at The Ohio State University College of Medicine. He also serves as Deputy Director of the Dorothy M. Davis Heart and Lung Research Institute. Dr. Abraham’s research interests include the role of the kidney in heart failure, neurohormonal mechanisms in heart failure, sleep disordered breathing in heart failure, and clinical drug and device trials in heart failure and cardiac transplantation. Dr. Abraham has received grants from the National Institutes of Health, the American College of Cardiology, and the Aetna Quality Care Foundation and has participated as Principal Investigator in more than 100 multicenter clinical drug and device trials. In addition to authoring more than 600 original papers, abstracts, book chapters, and review articles, Dr. Abraham has co-edited a leading textbook on heart failure entitled Heart Failure: A Practical Approach to Treatment.


Christopher P. Cannon MD, FACC

Harvard Medical School

Expertise: Acute Coronary Syndromes

A frequent lecturer and writer in the field of acute coronary syndromes, Dr. Cannon is an Associate Professor of Medicine at Harvard Medical School and an Associate Physician in the Cardiovascular Division at Brigham and Women’s Hospital in Boston. He is a senior investigator of the Thrombolysis In Myocardial Infarction (TIMI) Study Group. He is Editor-in-Chief of the journal Critical Pathways in Cardiology and the 35-book series Contemporary Cardiology. Dr. Cannon is editor or author of 6 books. He is the new Editor-in-Chief of the American College of Cardiology’s website Cardiosource (www.cardiosource.com).


Michael H. Davidson MD

University of Chicago

Expertise: Lipid Disorders

Michael H. Davidson, MD, is a Clinical Professor at the University of Chicago, where he also serves as Director of Preventive Cardiology and Associate Vice Chairman for Continuing Medical Education. In addition, he is Founder, President, and Chief Executive Officer of the Chicago Center for Clinical Research, currently part of Radiant Research. Dr. Davidson’s clinical research background encompasses both pharmaceutical and nutritional clinical trials. His extensive research on statins, novel lipid-lowering drugs, and nonpharmacologic risk factor reduction has established him as a key opinion leader in this area. A prolific author and lecturer on lipid disorders, nutrition, and atherosclerosis, Dr. Davidson has coordinated more than 700 clinical trials in areas of preventive cardiology and published more than 200 articles for leading medical journals.


Bernard J. Gersh MB, ChB, Dphil, FRCP, FACC

Mayo Clinic

Expertise: Ischemic Heart Disease

Dr. Gersh serves as Professor of Medicine as well as Consultant and Associate-Chair of Academic Affairs and Faculty Development at Mayo College of Medicine, Rochester, MN. His interests include the natural history and therapy of acute and chronic hypertrophic coronary heart disease, the cardiomyopathies, and the clinical implications of molecular genetics. In addition to authoring over 450 articles and over 90 book chapters, he is the editor of 10 books and is on the editorial board of 18 journals including Circulation, Journal of the American College of Cardiology, Nature Cardiovascular Medicine, and The European Heart Journal.


Alice K. Jacobs MD, FACC, FAHA

Boston University School of Medicine

Expertise: Women and Heart Disease

A leading authority in the treatment of patients with coronary artery disease and in evaluating gender differences in patients undergoing coronary revascularization, Dr. Jacobs is Professor of Medicine at Boston University and Director of the Cardiac Catheterization Laboratory and Interventional Cardiology at Boston University Medical Center. In June of 2003, she was named President-elect of the American Heart Association.


Dean J. Kereiakes MD

Ohio State University

Expertise: New Drugs and Devices

An active clinical and scientific investigator, Dr. Kereiakes is Medical Director of The Christ Hospital Heart and Vascular Center and The Lindner Center for Research and Education; Chairman, Executive Committee at The Ohio Heart and Vascular Center; and Professor of Clinical Medicine at Ohio State University. Dr. Kereiakes serves on the scientific advisory boards for multiple medical device companies and on the editorial boards of every major cardiovascular journal. He maintains an active practice in interventional cardiology.


Bradley P. Knight MD, FACC, FHRS

University of Chicago

Expertise: Heart Rhythm Disorders

Bradley P. Knight, MD, FACC, FHRS As Professor of Medicine at the University of Chicago, Dr. Knight is recognized as a leader in the field of heart rhythm disorders. He is an expert in catheter ablation, including ablation for atrial fibrillation, and he has been the Director of Clinical Cardiac Electrophysiology at the University of Chicago since 2002. His interests include imaging during ablation procedures and the differential diagnosis of supraventricular tachycardias in the electrophysiology laboratory.


Mikhail Kosiborod MD, FACC, FAHA

Expertise: Diabetes and heart disease

Dr. Kosiborod is a cardiologist and a clinical scholar at Saint Luke’s Mid America Heart Institute, and Associate Professor of Medicine at the University of Missouri-Kansas City. His main research interests include diabetes and glucose management in patients with acute coronary syndromes. He has authored and co-authored many peer-reviewed publications and abstracts, including several scientific statements and position documents on in-hospital and long-term glucose control. Dr. Kosiborod is a recipient of several American Heart Association research awards. He is actively involved in the work of many committees for the American College of Cardiology and American Heart Association.


Richard W. Nesto MD, FACC

Lahey Clinic Medical Center; Harvard Medical School

Expertise: Diabetic Cardiovascular Disease

As Chairman of the Department of Cardiovascular Medicine at Lahey Clinic Medical Center, Burlington, MA and Associate Professor of Medicine at Harvard Medical School, Dr. Nesto, a leader in the field of heart disease in diabetic patients, has been instrumental in the movement that has shown coronary heart disease to be commonly silent, and that treatment of coronary disease in diabetics requires a specialized approach. Dr. Nesto was recently selected to be the physician spokesperson for the AHA's national campaign on diabetes as a cardiovascular risk factor.


Gerald Pohost MD, FACC, FAHA

University of Southern California; Loma Linda University School of Medicine

Expertise: Cardiovascular Imaging

Dr. Pohost is known worldwide for his contributions to cardiovascular imaging. His pioneering efforts led to the development of thallium for clinical myocardial imaging and the field of cardiovascular MRI. His leadership led to the establishment of the International Society for Magnetic Resonance in Medicine and the Society for Cardiovascular Magnetic Resonance. He is a Professor at the Keck School of Medicine and the Viterbi School of Engineering at the University of Southern California, and a Professor at the Loma Linda University School of Medicine.


Matthew J. Price MD, FACC, FSCAI

Expertise: Interventional cardiology

Dr. Price is an interventional cardiologist and currently serves as Director of the Cardiac Catheterization Laboratory in the Cardiovascular Division of Scripps Clinic and Assistant Professor at the Scripps Translational Science Institute. Dr. Price has published numerous papers and chapters on high-risk percutaneous coronary intervention (PCI), drug-eluting stents, and the impact of antiplatelet therapy on outcomes after stent implantation. He is involved in the leadership of several trials examining the safety and efficacy of antiplatelet therapy during and after PCI.


Prediman K. Shah MD, FACC, FACP, FCCP

The David Geffen School of Medicine at UCLA

Expertise: Molecular Cardio-biology

A world-renowned investigator in vascular biology and acute coronary syndromes, also known for clinical expertise in coronary artery disease, acute ischemic syndromes and chronic heart failure, Dr. Shah is Shapell and Webb Chair and Director, Division of Cardiology and Atherosclerosis Research Center at Cedars-Sinai Medical Center, and Professor of Medicine at the David Geffen School of Medicine at UCLA.


Karol E. Watson MD, PhD

The David Geffen School of Medicine at UCLA

Expertise: Lipid Disorders

The recipient of prestigious awards, such as the Robert Wood Johnson Minority Medical Faculty Development and Merck/UNCF Postdoctoral Fellowship awards, Dr. Watson is Co-Director of the University of California, Los Angeles (UCLA) Program in Preventive Cardiology and Director of the UCLA Center for Cholesterol and Hypertension Management. She is also Assistant Professor of Medicine in the Division of Cardiology at the David Geffen School of Medicine at UCLA and Associate Director of the UCLA Fellowship Program in Cardiovascular Diseases.